HNGE insider plans sale of 19,659 Class A shares via Rule 144

HNGE filed a notice under Rule 144 for a proposed sale of restricted or control securities.

Rhea-AI Filing Summary

HNGE filed a notice under Rule 144 for a proposed sale of restricted or control securities. The filing covers the planned sale of 19,659 shares of Class A stock through broker Merrill Lynch, with an aggregate market value of 961,521.69. These shares are part of a larger base of 37,919,155 shares outstanding and are expected to be sold on the NYSE on or about 12/01/2025. The seller originally acquired the 19,659 Class A shares from the issuer in a private placement on 07/03/2018, paying cash at that time.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does HNGE's Form 144 filing disclose?

The Form 144 discloses a planned sale of 19,659 shares of Class A common stock of HNGE under Rule 144, indicating an intention to sell restricted or control securities into the market.

How many HNGE shares are proposed to be sold and on which exchange?

The filing states that 19,659 Class A shares are to be sold, with trading expected on the NYSE.

What is the aggregate market value of the HNGE shares covered by this Form 144?

The notice lists an aggregate market value of 961,521.69 for the 19,659 Class A shares proposed for sale.

When were the HNGE shares acquired and how were they purchased?

The 19,659 Class A shares were acquired on 07/03/2018 in a private placement from the issuer, with the consideration paid in cash on the same date.

How many HNGE shares are outstanding according to the Form 144?

The filing reports that there are 37,919,155 shares of the relevant class of HNGE stock outstanding.

What is the approximate date of sale for the HNGE shares in this Form 144?

The proposed sale date for the 19,659 Class A shares is listed as 12/01/2025, which is an approximate timing for execution.

Who is the broker for the HNGE Form 144 sale?

The broker named in the filing is Merrill Lynch, located at One Bryant Park, New York, NY 10036.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/01/2025 - 05:22 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001710834
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Hinge Health, Inc.
SEC File Number	001-42657
Address of Issuer	1114 Avenue of the Americas New York NEW YORK 10036
Phone	415-689-8429
Name of Person for Whose Account the Securities are To Be Sold	Insight Venture Partners X (Co Investors), L.P.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Board Member

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Merrill Lynch One Bryant Park New York NY 10036	19659	961521.69	37919155	12/01/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	07/03/2018	Private Placement	Issuer			19659	07/03/2018	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	12/01/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Jonathan Grossman
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)